182 related articles for article (PubMed ID: 10681328)
1. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.
Matsumoto S; Wakai Y; Nakai T; Hatano K; Ushitani T; Ikeda F; Tawara S; Goto T; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):619-21. PubMed ID: 10681328
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis.
Ikeda F; Wakai Y; Matsumoto S; Maki K; Watabe E; Tawara S; Goto T; Watanabe Y; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):614-8. PubMed ID: 10681327
[TBL] [Abstract][Full Text] [Related]
3. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
5. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of micafungin alone or in combination against experimental pulmonary aspergillosis.
Clemons KV; Stevens DA
Med Mycol; 2006 Feb; 44(1):69-73. PubMed ID: 16805095
[TBL] [Abstract][Full Text] [Related]
7. Comparative antifungal activities and plasma pharmacokinetics of micafungin (FK463) against disseminated candidiasis and invasive pulmonary aspergillosis in persistently neutropenic rabbits.
Petraitis V; Petraitiene R; Groll AH; Roussillon K; Hemmings M; Lyman CA; Sein T; Bacher J; Bekersky I; Walsh TJ
Antimicrob Agents Chemother; 2002 Jun; 46(6):1857-69. PubMed ID: 12019101
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
9. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Ikeda F
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of SPK-843, a novel polyene antifungal, in comparison with amphotericin B, liposomal amphotericin B, and micafungin against murine pulmonary aspergillosis.
Kakeya H; Miyazaki Y; Senda H; Kobayashi T; Seki M; Izumikawa K; Yanagihara K; Yamamoto Y; Tashiro T; Kohno S
Antimicrob Agents Chemother; 2008 May; 52(5):1868-70. PubMed ID: 18299412
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice.
Ito M; Nozu R; Kuramochi T; Eguchi N; Suzuki S; Hioki K; Itoh T; Ikeda F
Antimicrob Agents Chemother; 2000 Sep; 44(9):2259-62. PubMed ID: 10952565
[TBL] [Abstract][Full Text] [Related]
12. Successful micafungin (FK463) treatment of invasive pulmonary aspergillosis in a patient with acute lymphoblastic leukemia in a phase II study.
Ota S; Tanaka J; Kahata K; Toubai T; Kondo K; Mori A; Toyoshima N; Musashi M; Asaka M; Imamura M
Int J Hematol; 2004 May; 79(4):390-3. PubMed ID: 15218972
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment with micafungin of invasive pulmonary aspergillosis in acute myeloid leukemia, with renal failure due to amphotericin B therapy.
Yokote T; Akioka T; Oka S; Fujisaka T; Yamano T; Hara S; Tsuji M; Hanafusa T
Ann Hematol; 2004 Jan; 83(1):64-6. PubMed ID: 14661114
[TBL] [Abstract][Full Text] [Related]
14. Micafungin: a therapeutic review.
Higashiyama Y; Kohno S
Expert Rev Anti Infect Ther; 2004 Jun; 2(3):345-55. PubMed ID: 15482200
[TBL] [Abstract][Full Text] [Related]
15. [Antifungal activity and clinical efficacy of micafungin (funguard)].
Ikeda F
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
[TBL] [Abstract][Full Text] [Related]
16. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
[TBL] [Abstract][Full Text] [Related]
17. [New antifungal agents].
Miyazaki Y; Kawano S
Jpn J Antibiot; 2002 Dec; 55(6):911-2. PubMed ID: 12664932
[No Abstract] [Full Text] [Related]
18. Micafungin (FK463), alone or in combination with other systemic antifungal agents, for the treatment of acute invasive aspergillosis.
Denning DW; Marr KA; Lau WM; Facklam DP; Ratanatharathorn V; Becker C; Ullmann AJ; Seibel NL; Flynn PM; van Burik JA; Buell DN; Patterson TF
J Infect; 2006 Nov; 53(5):337-49. PubMed ID: 16678903
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi.
Tawara S; Ikeda F; Maki K; Morishita Y; Otomo K; Teratani N; Goto T; Tomishima M; Ohki H; Yamada A; Kawabata K; Takasugi H; Sakane K; Tanaka H; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Jan; 44(1):57-62. PubMed ID: 10602723
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacies of conventional amphotericin b, liposomal amphotericin B (AmBisome), caspofungin, micafungin, and voriconazole alone and in combination against experimental murine central nervous system aspergillosis.
Clemons KV; Espiritu M; Parmar R; Stevens DA
Antimicrob Agents Chemother; 2005 Dec; 49(12):4867-75. PubMed ID: 16304147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]